1. Home
  2. WVE vs HLIO Comparison

WVE vs HLIO Comparison

Compare WVE & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • HLIO
  • Stock Information
  • Founded
  • WVE 2012
  • HLIO 1970
  • Country
  • WVE Singapore
  • HLIO United States
  • Employees
  • WVE N/A
  • HLIO N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • HLIO Metal Fabrications
  • Sector
  • WVE Health Care
  • HLIO Industrials
  • Exchange
  • WVE Nasdaq
  • HLIO Nasdaq
  • Market Cap
  • WVE 2.1B
  • HLIO 1.7B
  • IPO Year
  • WVE 2015
  • HLIO N/A
  • Fundamental
  • Price
  • WVE $10.99
  • HLIO $43.93
  • Analyst Decision
  • WVE Strong Buy
  • HLIO Buy
  • Analyst Count
  • WVE 10
  • HLIO 2
  • Target Price
  • WVE $21.60
  • HLIO $63.00
  • AVG Volume (30 Days)
  • WVE 1.0M
  • HLIO 154.7K
  • Earning Date
  • WVE 03-05-2025
  • HLIO 02-24-2025
  • Dividend Yield
  • WVE N/A
  • HLIO 0.82%
  • EPS Growth
  • WVE N/A
  • HLIO N/A
  • EPS
  • WVE N/A
  • HLIO 1.13
  • Revenue
  • WVE $53,610,000.00
  • HLIO $819,800,000.00
  • Revenue This Year
  • WVE N/A
  • HLIO N/A
  • Revenue Next Year
  • WVE $48.58
  • HLIO $1.35
  • P/E Ratio
  • WVE N/A
  • HLIO $38.86
  • Revenue Growth
  • WVE N/A
  • HLIO N/A
  • 52 Week Low
  • WVE $3.50
  • HLIO $39.08
  • 52 Week High
  • WVE $16.74
  • HLIO $57.29
  • Technical
  • Relative Strength Index (RSI)
  • WVE 34.06
  • HLIO 35.56
  • Support Level
  • WVE $10.57
  • HLIO $43.24
  • Resistance Level
  • WVE $12.03
  • HLIO $46.07
  • Average True Range (ATR)
  • WVE 0.69
  • HLIO 1.27
  • MACD
  • WVE -0.17
  • HLIO 0.08
  • Stochastic Oscillator
  • WVE 12.54
  • HLIO 19.66

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HLIO Helios Technologies Inc.

Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness.

Share on Social Networks: